Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Gynecologic Oncology Research and Practice|December 2, 2016
The role of immune checkpoint inhibition in the treatment of ovarian cancerStéphanie L Gaillard, Angeles A Secord, Bradley MonkGynecologic Oncology|December 2, 2017
Urinary diversion in the genitourinary cancer survivorOmari K Johnson, Andrew Berchuck, Angeles A Secord, et al.Obstetrics and Gynecology|March 15, 2019
U.S. Food and Drug Administration-Approved Poly (ADP-Ribose) Polymerase Inhibitor Maintenance Therapy for Recurrent Ovarian Cancer: A Cost-Effectiveness AnalysisJoseph A Dottino, Haley A Moss, Karen H Lu, et al.Nature Reviews. Clinical Oncology|March 11, 2015
Patient-reported outcomes as end points and outcome indicators in solid tumoursAngeles A Secord, Robert L Coleman, Laura J Havrilesky, et al.International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|December 5, 2013
Cystic fibrosis involving the cervix, mimicking a well-differentiated adenocarcinoma: a case reportRebecca A Previs, James M Edwards, Angeles A Secord, et al.Gynecologic Oncology|July 7, 2015
Comparison of bevacizumab alone or with chemotherapy in recurrent ovarian cancer patientsKatherine C Fuh, Angeles A Secord, Kerri S Bevis, et al.Gynecologic Oncology|January 8, 2017
Prior breast cancer and tamoxifen exposure does not influence outcomes in women with uterine papillary serous carcinomaStuart R Pierce, Jessica E Stine, Paola A Gehrig, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 9, 2011
MHC class I-presented tumor antigens identified in ovarian cancer by immunoproteomic analysis are targets for T-cell responses against breast and ovarian cancerMichael A Morse, Angeles A Secord, Kimberly Blackwell, et al.International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|July 13, 2017
Prospective Evaluation of Lymph Node Processing at Staging Surgery for High-grade Endometrial CancerBrittany A Davidson, Jessie Ehrisman, Sara Abbott, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 10, 2022
Randomized Phase III Trial of Paclitaxel and Carboplatin Versus Paclitaxel and Ifosfamide in Patients With Carcinosarcoma of the Uterus or Ovary: An NRG Oncology TrialMatthew A Powell, Virginia L Filiaci, Martee L Hensley, et al.Pageof 1